MeiraGTx | Company Profile - Revenue, Headcount, Tech Stack, Contacts

MeiraGTx | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Updated November 14, 2025
Public ProfileLinkedInLinkedIn Profile

MeiraGTx is a clinical-stage genetic medicines company founded in 2015.

Employees114
Revenue$34.5M
Market Cap702.3M
Alexa Rank# 462396

Industry & Market

Primary Industry
biotechnology
Location
London, England, United Kingdom
Public Trading
NASDAQ: MGTX

Funding Information

Annual Revenue
$34,508,000
Publicly traded company

Headcount Distribution

Total Employees
114
Departments
19

By Department

Department Breakdown

Engineering
Operations
Information Technology
Finance
Education
Human Resources
Others

Keywords & Focus Areas

biotechgene therapylife sciencesrare diseaseneurodegenerative diseaseinherited retinopathiesbiotechnology: biological products (no diagnostic substances)health careregenerative medicinerna-based diagnosticsviral vector designservicessmall molecule inducersviral vector processrna sequencing technologiesrna in virologyrna structural motifsgene therapy manufacturinggene therapy vector designgene therapy innovation+10 more
30 total keywords

Overview

MeiraGTx is a clinical-stage genetic medicines company founded in 2015. It specializes in developing gene therapies for severe inherited and acquired diseases, focusing on conditions with significant unmet medical needs, such as inherited eye diseases, Parkinson’s disease, and radiation-induced xerostomia. The company has a broad pipeline of gene therapy candidates, including four late-stage clinical programs.

It develops advanced viral vectors to ensure effective and safe delivery of therapeutic genes and operates five global manufacturing facilities, two of which are licensed for GMP viral vector production. A notable innovation is the riboswitch gene regulation platform, enabling precise in vivo control of gene expression, applied across therapies for metabolic peptides, cell therapies for cancer, and chronic pain. In 2025, a joint venture with Hologen was launched to advance gene therapies for Parkinson’s disease and obesity.

Key Metrics

Total Employees
XXXX
Total number of employees
Engineering
XX
Number of employees in the engineering department
Sales Team
$XX
Number of employees in the sales department
Marketing
XX
Number of employees in the marketing department
Founded
XXXX
Year the company was founded
Revenue
$XXX,XXX,XXX
Total revenue of the company
Total Funding
$XXX M
Total funding of the company
Market Cap
$XXX,XXX
Market cap of the company

Get Complete Company Metrics

Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.

Start For Free

Contact

Company
MeiraGTx
Headquarters
92 Brittania Walk, London/New York, N17NQ, GB
Founded
2015
Industry
Biotechnology

Technology Stack

Analytics & Tracking

Google AnalyticsGoogle Tag Manager

Social & Marketing

Not found

Database & Backend

Google Font API

Cloud & Infrastructure

Google Cloud Hosting

Productivity

Not found

Compare similar companies to MeiraGTx

Compare insights from companies similar to MeiraGTx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company NameRevenueNo. of EmployeesTypeFundingFounded InTop Executive
xx
$10253142Private-9232
xxxxxxxxx
xxxxx
$4461214Private-6615
xxx
xxxxxxx
$258090Private-5889
xxxxxxx
xxxxxx
$93866149Private-8752
x
xxxxxxx
$9808078Private-4446
xxxxxxxxx

Discover Similar Companies Instantly

Explore detailed insights and analysis on companies related to your search.

Start For Free

Turn this profile into a pipeline

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free